Samer A. Srour, MB ChB, MS, has long hoped the remarkable success of chimeric antigen receptor therapy for treatment of hematologic malignancies could be replicated in other cancer types.“There is a ...
Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...
Griffith University researchers have shown that the shape and surface chemistry of microscopic "re-entrant" structures—tiny overhanging caps arranged like mushroom tops—can tune how cancer cells stick ...
Researchers identified immune cells that attacked the neuronal protein C9orf72 in individuals with ALS, spurring new ...
The Nobel Prize in Medicine was awarded on Monday to three scientists for discovering how a particular kind of cell can stop ...
“It’s possible that the mice weren’t seeing them,” admits Shin, “because the technique has involved a relatively small number ...
In late September and early October 2025, Facebook users spread a warning about a scheme apparently putting its victims in danger. The message, framed as a "police warning" to women in particular, ...
Takeda is tapping out of the cell therapy arena as part of a "strategic portfolio reprioritization," with 137 roles at the drugmaker's Massachusetts R&D site affected. The company is seeking a partner ...
Emma Guttman, MD, PhD, discusses the promising potential of rocatinlimab in targeting the OX40-OX40 ligand pathway for atopic dermatitis treatment. Trial investigator Emma Guttman, MD, PhD, chair of ...
From the outset, SpaceX's tenth Starship test flight in late August looked like a near-perfect success. The massive rocket had a clean launch from Starbase, sailed smoothly into space, and guided ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback